FIELD: medicine.
SUBSTANCE: the suggested peroral preparation of controlled release contains 2-amino-3-cyano-5-(2-fluorophenyl)-4-methylpyrrole as an active ingredient. T is applied for treating pollakiuria and incontinence of urine. Application of the suggested preparation provides better quality of life in a patient who should follow certain schedule and scheme of therapy without any excessive increase in the level of medicinal preparation in blood plasma due to controlling the rate for preparation's release in vivo and, also, due to decreased frequency in the intake of the suggested medicinal preparation.
EFFECT: higher efficiency of therapy.
16 cl, 4 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL SOLID PREPARATION OF COMPOUND ANTITUBERCULOSIS DRUG AND PREPARATION METHOD THEREOF | 2012 |
|
RU2605388C2 |
| TACROLIMUS FOR IMPROVED TREATMENT OF PATIENTS WITH GRAFTS | 2009 |
|
RU2574006C2 |
| PHARMACEUTICAL COMPOSITION FOR PERORAL INTRODUCTION IN FORM OF PARTICLES WITH CALCULATED TIME OF RELEASE AND QUICKLY DECOMPOSING TABLETS CONTAINING SAID COMPOSITION | 2005 |
|
RU2382637C2 |
| SOLID DISPERSION CONTAINING ACTIVE COMPONENT WITH LOW FUSION TEMPERATURE, AND ORAL TABLET CONTAINING IT | 2006 |
|
RU2403013C2 |
| CONTROLLED-RELEASE HYDROCODON COMPOSITION | 2001 |
|
RU2253452C2 |
| COMPOSITION CONTAINING DEMENTIA DRUG | 2006 |
|
RU2445092C2 |
| NEW CONTROLLED-RELEASE GRANULES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH GRANULES | 1995 |
|
RU2141822C1 |
| VITAMIN COMPOSITION WITH SUSTAINED-RELEASE OF ACTIVE COMPONENT | 2001 |
|
RU2248200C2 |
| COMBINED COMPOSITION CONTAINING METFORMIN OF SUSTAINED RELEASE AND INHIBITOR HMG-CoA-REDUCTASE OF IMMEDIATE RELEASE | 2014 |
|
RU2651460C2 |
| MEDICINAL CONTROLLED-RELEASING FORMS OF AZITHROMYCIN | 1995 |
|
RU2130311C1 |
